SRGA - Surgalign Holdings, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
0.8300
+0.0700 (+9.21%)
At close: 04:00PM EDT
0.8400 +0.01 (+1.20%)
After hours: 07:28PM EDT
Stock chart is not supported by your current browser
Previous close0.7600
Open0.7649
Bid0.7258 x 1200
Ask0.8400 x 800
Day's range0.7601 - 0.8300
52-week range0.6600 - 6.7700
Volume42,899
Avg. volume86,347
Market cap7.622M
Beta (5Y monthly)1.80
PE ratio (TTM)N/A
EPS (TTM)-8.5600
Earnings date07 Aug 2023 - 11 Aug 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.25
  • GlobeNewswire

    Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources

    Company to showcase its upgraded HOLO Portal™ Surgical Guidance System and key products in its hardware spine and biologics portfolio DEERFIELD, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, announced today that it will be exhibiting at ISASS 2023 – the 23rd Annual Conference – sponsored by the International Society for Spine Surgery (“ISASS”

  • GlobeNewswire

    Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations

    DEERFIELD, Ill., May 11, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2023 first quarter ended March 31, 2023. 2023 First Quarter and Subsequent Corporate Highlights: Launch of HOLO™ AI Insights for Spine Imaging; collaboration with Dr. Alexander Vaccaro, Dr. Pierce Nunley and Spine Institute of Louisiana, and le

  • GlobeNewswire

    Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Research

    New HOLO AI Insights application aims to advance research of neuroanatomy utilizing artificial intelligenceDEERFIELD, Ill., May 08, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is proud to announce today, the release of HOLO™ AI Insights for use in neurovascular research. HOLO AI Insights, initially launched in March 2023 for spine imaging, enables custom

  • GlobeNewswire

    Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023

    DEERFIELD, Ill., May 04, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its first quarter 2023 after the close of trading on May 11, 2023. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (888) 437-3179 (U.S.) or 862

  • GlobeNewswire

    Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies

    DEERFIELD, Ill., May 03, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is pleased to announce new collaborative alliances with Dr. Pierce Nunley and the Spine Institute of Louisiana, a prestigious medical facility and one of the top 20 patient-rated U.S. hospitals for best overall care, and Dr. Alexander Vaccaro, an advisor to Surgalign and one of the top-

  • GlobeNewswire

    Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance

    DEERFIELD, Ill., April 13, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, announced today that on April 10, 2023, it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is no longer in compliance with the $10 million minimum stockholders’ equity requirement for co

  • Simply Wall St.

    Surgalign Holdings Full Year 2022 Earnings: EPS Misses Expectations

    Surgalign Holdings ( NASDAQ:SRGA ) Full Year 2022 Results Key Financial Results Revenue: US$82.0m (down 9.4% from FY...

  • GlobeNewswire

    Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results

    DEERFIELD, Ill., March 30, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today reported operating results for its fourth quarter and full year 2022 ending December 31, 2022. 2022 Fourth Quarter and Subsequent 2023 Corporate Highlights: Expansion of HOLO Portal™ into Virginia and Texas; over 30 cases performed since commercial launchLaunched HOLO™ AI Insig

  • GlobeNewswire

    Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023

    DEERFIELD, Ill., March 21, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its fourth quarter and full year 2022 after the close of trading on March 30, 2023. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (866) 604

  • GlobeNewswire

    Surgalign Launches Next Generation Software for its HOLO Portal™ Surgical Guidance System and Expands Surgical Tool Integration to Drive Use Case Adoption

    The next iteration of HOLO Portal delivers advancements based on early clinical experience and insights from leading spine surgeons in the U.S.DEERFIELD, Ill., March 20, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced the first major upgrade of the HOLO Portal™ Surgical Guidance System since the first case was performed in May of 2022. Since

  • GlobeNewswire

    Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023

    DEERFIELD, Ill., March 16, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it will be hosting its 2023 Annual Meeting of Shareholders virtually, on Thursday, June 1, 2023 at 9 a.m. PT. Shareholders will be able to access the Company’s Proxy Statement and Annual Report on Form 10-K once they are filed with the Securities and Exchange Comm

  • GlobeNewswire

    Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging

    Surgalign’s HOLO AI Insights aims to enhance clinical decision making through the power of AI technologyDEERFIELD, Ill., March 13, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is proud to announce the release of HOLO AI Insights. HOLO AI Insights enables customers, partners, and clinical researchers to take advantage of the Company’s HOLO artificial intel

  • GlobeNewswire

    Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance

    Company on track to achieve target cash savings of $30 - $35 million in 2023 vs 2022; expects to report 2022 revenue of approximately $82.0 million and end the year with a cash balance in excess of $16 millionDEERFIELD, Ill., March 06, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today provided updates on its previously announced restructuring plan. On N

  • GlobeNewswire

    Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas

    Dr. Rick C. Sasso, renowned spinal surgeon to highlight Surgalign’s HOLO Portal™ Surgical Guidance System on the OrthoDome Panel on March 8, 2023DEERFIELD, Ill., March 03, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced its participation at the 2023 American Academy of Orthopaedic Surgeons (“AAOS”) Annual Meeting, which will take place March

  • GlobeNewswire

    Medical City Frisco is the Latest Hospital to Utilize Surgalign’s HOLO Portal Surgical Guidance System

    This represents the first site in Texas; Medical City Frisco to leverage the benefits of HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR) system for spine surgeryDEERFIELD, Ill., March 02, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that Medical City Frisco, a world-class acute care hospital in F

  • GlobeNewswire

    Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million

    Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital Health Strategy BELGRADE, Mont. and DEERFIELD, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, and Surgalign Holdings, Inc., (NASDAQ: SRGA), a global medical technology company focused o

  • GlobeNewswire

    Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System

    DEERFIELD, Ill., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced a key milestone for its recently introduced posterior fixation platform – the Cortera™ Spinal Fixation System. Surgalign received FDA 510(k) in August 2022 and Cortera and was introduced in a limited market release shortly thereafter. In a little over three months, the

  • GlobeNewswire

    Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance System in Virginia

    Richmond, VA medical facility is fourth to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgeryDEERFIELD, Ill., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced additional commercialization of its HOLO Portal surgical guidance system. The Company is

  • GlobeNewswire

    Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

    DEERFIELD, Ill., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that the closing of its previously announced registered direct offering priced at the market under Nasdaq rules of 6,000,000 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and Series A warrants to purchase up to 6,000,000 shares of common

  • GlobeNewswire

    Surgalign Announces $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

    DEERFIELD, Ill., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that it has entered into a definitive agreement with a single institutional investor for the sale and issuance of 6,000,000 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and Series A warrants to purchase up to 6,000,000 shares of common

  • GlobeNewswire

    Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas

    Company plans to realign in an effort to improve efficiencies, while lowering its capital requirements to invest in innovation; estimated cash savings in 2023 are expected to be approximately $30 - $35 millionDEERFIELD, Ill., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that its Board of Directors has approved a corporate restruct

  • GlobeNewswire

    Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook

    DEERFIELD, Ill., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 third quarter ended September 30, 2022. 2022 Third Quarter Corporate Highlights: Two new clinical sites in Ohio utilize the HOLO PortalTM surgical guidance system.FDA 510(k) clearance of the Cortera™ Spinal Fixation System, the first orga

  • GlobeNewswire

    Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022

    DEERFIELD, Ill., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its third quarter ended September 30, 2022 after the close of trading on November 2, 2022. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (86

  • GlobeNewswire

    Surgalign™ Awarded 2022 Best New Technology Award from Orthopedics This Week for its HOLO Portal™ Surgical Guidance System

    World’s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgery recognized by panel of leading orthopedic surgeonsDEERFIELD, Ill., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its HOLO Portal surgical guidance system won the 2022 Best New Spine Technology Award presented by Orthopedics T

  • GlobeNewswire

    Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

    DEERFIELD, Ill., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has granted restricted stock unit awards to two (2) employees, none of whom was an executive officer, as an inducement for them to accept employment with Surgalign, and representing the right to receive, in the aggregate, up to 10,081 shares of Surgalign common